On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
71° Feels Like: 71°
Wind: SW 8 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 71°

Tonight

Isolated Thunderstorms 51°

Tomorrow

PM Thunderstorms 77°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

FDA postpones panel for Glaxo's COPD drug as snowstorm advances

A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville

(Reuters) - The Food and Drug Administration said on Tuesday it has postponed a meeting of outside advisers scheduled for March 7 to review a drug developed by GlaxoSmithKline Plc and Theravance Inc for chronic obstructive pulmonary disease (COPD).

The agency did not officially give a reason for the postponement but it comes as a major snowstorm bears down on the Northeastern United States, including Washington D.C., where the panelists were due to meet.

The agency said it would post briefing materials related to the drug, to be called Breo if approved in the United States, no later than two days before the next meeting, once announced.

(Reporting By Toni Clarke in Washington)

Comments